Month: June 2023

8 June 2023 PRESS RELEASE Ad hoc announcement pursuant to Art. 53 Listing Rules: GAM receives request for an EGM from a shareholderRock Investment SAS requests an EGM to change the board and the articles This request does not constitute an offer to GAM shareholders The GAM Board continues to strongly recommend that shareholders accept the Liontrust proposal as supported by the GAM Portfolio ManagersLate on the evening of 7 June 2023, GAM Holding AG received a request from Rock Investment SAS (part of the investor group comprised of Newgame SA and Bruellan SA) who holds 5.11% of GAM shares to hold an extraordinary general meeting (EGM) of shareholders on or about 16 August 2023. This would be subsequent to the results of the Liontrust tender offer being known, based on the current timeline.  The proposed EGM would contemplate the...

Sandoz well positioned to deliver continued mid-single digit sales growth; core EBITDA margin of 24-26% and Free Cash Flow to more than double over mid termEuropean champion committed to further extending global leadership in attractive and growing generics and biosimilars market, via purpose-driven strategy with focus on access and sustainabilitySix strategic levers to drive long-term investor value; attractive financial outlook, including targeted investment grade credit profile and progressive dividend policyNew York, June 8, 2023 — Sandoz today hosts the first of two Capital Markets Days (CMDs) for investors, in New York City, to set out its plans for growth and success as a standalone company, following the proposed 100% spin-off from Novartis. Sandoz reported sales of USD 9.1 bn in 2022, with a record of six consecutive...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, June 08, 2023 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial or fungal infections, reported today that sales of the antifungal Cresemba® (isavuconazole) by its license partner Pfizer in Europe and the Asia Pacific and China regions, respectively, exceeded thresholds that triggered two separate milestone payments totaling USD 26.25 million to Basilea. David Veitch, Chief Executive Officer of Basilea, said: “These sales milestone events confirm that Cresemba continues to serve a medical need in patients suffering from life-threatening invasive mold infections in many countries across the globe.” Based on the license agreement between Basilea and Pfizer, Basilea...

The shareholders of Mendus AB (publ) (the “Company”), reg. no 556629-1786, are hereby invited to the Extraordinary General Meeting (“EGM”) on Monday, 10 July 2023, at 09:30 a.m. at Tändstickspalatset, Västra Trädgårdsgatan 15, Stockholm. Registration for the meeting will commence at 09:00 a.m.NOTIFICATION Shareholders who wish to attend the meeting must:both be recorded in the share register maintained by Euroclear Sweden AB on the record date on Friday, 30 June 2023; and not later than on Tuesday, 4 July 2023 have notified their attendance and possible advisors to the Company; either in writing via letter to Mendus AB (publ), “EGM”, Västra Trädgårdsgatan 15, SE-111 53 Stockholm, Sweden, or by e-mail to info@mendus.com.The notification shall include full name, personal/corporate identity number, address, daytime telephone number...

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL OR DEMAND ADDITIONAL REGISTRATION OR OTHER MEASURES. PLEASE REFER TO “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE.As announced through a separate press release, Mendus AB (publ) (“Mendus” or the “Company”), (NASDAQ Stockholm: IMMU) and NorthX Biologics (“NorthX”), a Flerie Invest AB (“Flerie”) portfolio company, have entered into a strategic manufacturing alliance. In connection with this alliance, the Board of Directors of Mendus has resolved on a capital raise of approximately SEK 317 million...

Ad hoc announcement pursuant to Art. 53 LR The closing of the purchase agreement signed on May 12, 2023 was implemented on June 7, 2023. This strategic decision allows Feintool to concentrate on its core business of series parts production. The entrepreneurial orientation of the new owner CERTINA creates best conditions for the capital goods business to further expand its leading position. With the divest of the capital goods business, the Feintool Group has positioned itself as a pure player in the business area of high volume parts production manufactured by the technological processes of fineblanking, forming, and electrolamination stamping. This comprises a portfolio of state-of-the-art tooling solutions across the entire process chain through to innovative product solutions for electric motors. Feintool and the CERTINA GROUP are...

MARLBOROUGH, Mass., June 07, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the pricing of its public offering of 8,700,000 shares of common stock (the “Offering”) at a public offering price of $5.00 per share for gross proceeds of approximately $43.5 million, without giving effect to the underwriting discount and commission as well as estimated expenses payable by Akoya. Akoya has granted the underwriters a 30-day option to purchase up to an additional 1,305,000 shares of its common stock at the public offering price. The closing of the Offering is expected to occur on June 12, 2023, subject to the satisfaction of customary closing conditions. Akoya intends to use the net proceeds from the Offering for working capital and general corporate purposes. Morgan...

HighlightsArcher Materials has advanced the room temperature capabilities of its qubit material, achieving unprecedented quantum coherence times. The long coherence times increases the time-window for processing quantum information at room temperature beyond that for any known, similar qubit materials. This milestone, which was previously only achieved at -173°C, means more complex computing applications could potentially be performed in more normal operating environments. Archer is the only ASX listed company and one of a few players in the world developing qubit processor technology.SYDNEY, Australia, June 08, 2023 (GLOBE NEWSWIRE) — Archer Materials Limited (“Archer”, the “Company”, “ASX: AXE”), a semiconductor company that advances the quantum computing and medical diagnostics industries, has reached a significant milestone...

GUANGZHOU, China, June 08, 2023 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”) is pleased to announce that our flagship comprehensive genomic profiling (CGP) product, OncoScreenTM Plus, was featured in a phase 3 multi-regional clinical trial (MRCT), along with FoundationOneCDx, in support of advancement in breast cancer treatment. The study, CAPItello-291, sponsored by our pharma client AstraZeneca, is a phase 3 trial that assessed the efficacy and safety of Capivasertib–fulvestrant therapy in advanced breast cancer patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) cancer whose disease had progressed during or after aromatase inhibitor therapy. The study demonstrated that Capivasertib–fulvestrant combination therapy...

SINGAPORE, June 07, 2023 (GLOBE NEWSWIRE) — PubMatic, (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, and Telkomsel, the largest mobile network operator in Indonesia, today announced a strategic partnership to provide data-driven digital advertising solutions for brands and agencies in Indonesia. Through the partnership, Telkomsel will make audience segments based on mobile customer insights available to advertisers programmatically through Connect, PubMatic’s audience solution. Connect allows advertisers to engage audiences through privacy-compliant solutions that perform — without relying on third-party cookies or outdated strategies. Furthermore, applying valuable audience segments, such as those from Telkomsel, on the sell-side brings greater efficiency to...